Moreover, sulfonylurea therapies could lower the blood glucose levels and raise plasma insulin levels in the untreated patients with diabetes mellitus and postprandial blood glucose levels and low plasma insulin levels [40]. The gene discussed is INS; the disease is diabetes mellitus.